ALT

ALT EBITDA Margin

-298787.10%TTM

Period ending:

ALT FY EBITDA Margin%
ALT FY EBITDA Margin195913.79%-545842.91%
2005-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

ALT ebitda margin history

EBITDA as a percentage of revenue. The available annual fiscal periods series contains 21 observations from Dec 31, 2005 to Dec 31, 2025.

Altimmune Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
-212,258.5366%
-474,060%
-20,642.0188%
124,130.8824%
-2,188.9796%
-465.5434%
-348.0033%
-432.8793%
-124,720.1576%
-208.6531%
-29.9115%
-93.5466%
-61.9945%
-16.1985%
-13.5246%
-110.781%
-103.703%
-100.3539%
-107.8837%
-760.3996%
55.5041%

Compare ebitda margin

All ALT financial metrics · ALT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.